Faron Pharmaceuticals - Innovative medical solutions (Part 2)

The Investment Advisor segment hasn’t changed at all. 63 retail investors have joined, 3 corporate owners have exited, but not with a significant number of shares. About 3 million shares have moved out of the “unknown” category, which have practically shifted into retail ownership.

Still, nothing suggests that HCM isn’t the seller. Their holdings haven’t been reviewed since mid-September (read: changes in HCM’s holdings don’t show up in these tables). The only thing that doesn’t support this is that no flagging notification has been made for dropping below the 5% threshold. Of course, they had 8–9 million shares above that level anyway.

2 Likes